BIND Therapeutics

BIND Therapeutics

BIND Therapeutics

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Founded
2006
Raised
$37.9M
Follow us
Alexa global traffic share
Twitter followers
13 Feb 2012
$25,500,000
Venture capital (Series D)
29 Jun 2010
$12,400,000
Venture capital (Series C)